Key result
In patients with acute decompensated heart failure without diabetes, each unit increase in the TyG index was associated with a 62.9% lower risk of 1-year all-cause mortality.
Why the study?
The relationship between a low TyG index and mortality risk in acute decompensated heart failure patients without diabetes remained unclear.
Is a low Triglyceride-Glucose (TyG) index associated with increased 1-year mortality in patients with acute decompensated heart failure without diabetes?
Cohort (n=652)
No
Is a low Triglyceride-Glucose (TyG) index associated with increased 1-year mortality in patients with acute decompensated heart failure without diabetes?
In patients with acute decompensated heart failure without diabetes, a lower TyG index is a significant predictor of increased 1-year all-cause and cardiovascular mortality.
Answers are grounded in this paper and cite their sources.
Low TyG index associated with higher mortality in nondiabetic acute HF; hypothesis-generating and requires prospective validation before clinical use.
Background: The relationship between a low TyG index and mortality risk in Acute Decompensated Heart Failure (ADHF) also remains unclear. This study aimed to investigate the association between a low TyG index and 1-year mortality in ADHF patients without diabetes. Methods: A total of 652 hospitalized patients with ADHF without diabetes from January, 2020 to May, 2023 were included in this retrospective study. The primary outcomes were all-cause mortality and cardiovascular mortality within one year. The association between the TyG index and both all-cause and cardiovascular mortality was investigated using restricted cubic splines and multivariate Cox proportional hazards models. Results: The study enrolled a total of 652 patients with acute decompensated heart failure (ADHF) who were free from diabetes (70.6% male). Within one year, there were 72 deaths from all causes and 40 deaths from cardiovascular disease. In multivariate Cox proportional hazards models, a significant negative relationship was observed between the TyG index and both all-cause mortality (hazard ratio [HR] = 0.371, 95% confidence interval [CI] 0.201-0.685) and cardiovascular mortality (HR = 0.336, 95% CI 0.151-0.744). The restricted cubic spline analysis illustrated a decrease in the risk of all-cause and cardiovascular mortality as the TyG index increased. Hypertension, BMI, age, atrial fibrillation significantly interacted with the TyG index in relation to all-cause mortality, while hypertension specifically interacted with the TyG index regarding cardiovascular mortality. Conclusion: In patients diagnosed with ADHF without diabetes, a lower TyG index is strongly related to a higher risk of 1-year all-cause and cardiovascular mortality. Therefore, it is important to pay close attention to low TyG index levels and implement appropriate measures in clinical practice.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a cohort in Acute Decompensated Heart Failure (ADHF) without diabetes (n=652). Triglyceride-Glucose (TyG) index vs. Higher TyG index was evaluated on 1-year all-cause mortality (HR 0.371, 95% CI 0.201-0.685, p=0.002). In patients with acute decompensated heart failure without diabetes, each unit increase in the TyG index was associated with a 62.9% lower risk of 1-year all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: